ID   NOS3_HUMAN              Reviewed;        1203 AA.
AC   P29474; A0S0A7; A0S0A8; A8KA63; B2RCQ1; E9PFR2; Q13662; Q14251; Q14434;
AC   Q548C1; Q6GSL5; Q9UDC6;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   28-MAR-2018, sequence version 4.
DT   18-JUN-2025, entry version 262.
DE   RecName: Full=Nitric oxide synthase 3 {ECO:0000312|HGNC:HGNC:7876};
DE            EC=1.14.13.39 {ECO:0000269|PubMed:1378832, ECO:0000269|PubMed:35772285};
DE   AltName: Full=Constitutive NOS;
DE            Short=cNOS;
DE   AltName: Full=EC-NOS;
DE   AltName: Full=NOS type III;
DE            Short=NOSIII;
DE   AltName: Full=Nitric oxide synthase, endothelial {ECO:0000305};
DE            Short=Endothelial NOS {ECO:0000305};
DE            Short=eNOS {ECO:0000305};
GN   Name=NOS3 {ECO:0000312|HGNC:HGNC:7876};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT GLU-298, CATALYTIC
RP   ACTIVITY, AND FUNCTION.
RX   PubMed=1378832; DOI=10.1016/s0021-9258(18)42066-2;
RA   Janssens S.P., Shimouchi A., Quertermous T., Bloch D.B., Bloch K.D.;
RT   "Cloning and expression of a cDNA encoding human endothelium-derived
RT   relaxing factor/nitric oxide synthase.";
RL   J. Biol. Chem. 267:14519-14522(1992).
RN   [2]
RP   ERRATUM OF PUBMED:1378832.
RA   Janssens S.P., Shimouchi A., Quertermous T., Bloch D.B., Bloch K.D.;
RL   J. Biol. Chem. 267:22694-22694(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLU-298.
RX   PubMed=1379542; DOI=10.1016/0014-5793(92)80697-f;
RA   Marsden P.A., Schappert K.T., Chen H.S., Flowers M., Sundell C.L.,
RA   Wilcox J.N., Lamas S., Michel T.;
RT   "Molecular cloning and characterization of human endothelial nitric oxide
RT   synthase.";
RL   FEBS Lett. 307:287-293(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLU-298.
RX   PubMed=7688726; DOI=10.1016/s0021-9258(19)85359-0;
RA   Marsden P.A., Heng H.H.Q., Scherer S.W., Stewart R.J., Hall A.V.,
RA   Shi X.-M., Tsui L.-C., Schappert K.T.;
RT   "Structure and chromosomal localization of the human constitutive
RT   endothelial nitric oxide synthase gene.";
RL   J. Biol. Chem. 268:17478-17488(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=7509596; DOI=10.1006/bbrc.1994.1146;
RA   Nadaud S.A., Bonnardeaux A., Lathrop M., Soubrier F.;
RT   "Gene structure, polymorphism and mapping of the human endothelial nitric
RT   oxide synthase gene.";
RL   Biochem. Biophys. Res. Commun. 198:1027-1033(1994).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLU-298.
RX   PubMed=7519987; DOI=10.1111/j.1432-1033.1994.tb19045.x;
RA   Miyahara K., Kawamoto T., Sase K., Yui Y., Toda K., Yang L.X., Hattori R.,
RA   Aoyama T., Yamamoto Y., Doi Y., Ogoshi S., Hashimoto K., Kawai C.,
RA   Sasayama S., Shizuta Y.;
RT   "Cloning and structural characterization of the human endothelial nitric-
RT   oxide-synthase gene.";
RL   Eur. J. Biochem. 223:719-726(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ENOS13B AND ENOS13C), ALTERNATIVE
RP   SPLICING, FUNCTION (ISOFORM ENOS13C), AND VARIANT GLU-298.
RX   PubMed=17264164; DOI=10.1096/fj.06-7434com;
RA   Lorenz M., Hewing B., Hui J., Zepp A., Baumann G., Bindereif A., Stangl V.,
RA   Stangl K.;
RT   "Alternative splicing in intron 13 of the human eNOS gene: a potential
RT   mechanism for regulating eNOS activity.";
RL   FASEB J. 21:1556-1564(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLU-298.
RC   TISSUE=Umbilical vein;
RA   Liao J.K.;
RL   Submitted (DEC-1993) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLU-298.
RC   TISSUE=Platelet;
RA   Zhang Y., Freedman J.E.;
RT   "The role of phosphatidylinositol-3-oh kinase in platelet-derived nitric
RT   oxide release and platelet disaggregation.";
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLU-298.
RC   TISSUE=Hippocampus, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLU-298.
RC   TISSUE=Spleen;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLN-112; GLU-298; MET-827;
RP   MET-885 AND LEU-982.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLU-298.
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLU-298.
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLU-298.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [16]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLU-298.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [17]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-53.
RC   TISSUE=Placenta;
RX   PubMed=7514568; DOI=10.1006/geno.1994.1068;
RA   Robinson L.J., Weremowicz S., Morton C.C., Michel T.;
RT   "Isolation and chromosomal localization of the human endothelial nitric
RT   oxide synthase (NOS3) gene.";
RL   Genomics 19:350-357(1994).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 411-528 (ISOFORM 1/ENOS13C).
RC   TISSUE=Platelet;
RX   PubMed=7475956; DOI=10.1016/0024-3205(95)02191-k;
RA   Sase K., Michel T.;
RT   "Expression of constitutive endothelial nitric oxide synthase in human
RT   blood platelets.";
RL   Life Sci. 57:2049-2055(1995).
RN   [19]
RP   PROTEIN SEQUENCE OF 167-175; 531-540; 835-845; 876-881; 886-898; 1001-1005
RP   AND 1068-1080, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=7515611; DOI=10.1006/abbi.1994.1232;
RA   Garvey E.P., Tuttle J.V., Covington K., Merrill B.M., Wood E.R.,
RA   Baylis S.A., Charles I.G.;
RT   "Purification and characterization of the constitutive nitric oxide
RT   synthase from human placenta.";
RL   Arch. Biochem. Biophys. 311:235-241(1994).
RN   [20]
RP   INTERACTION WITH NOSIP, ACTIVITY REGULATION, AND SUBCELLULAR LOCATION.
RX   PubMed=11149895; DOI=10.1096/fj.00-0078com;
RA   Dedio J., Koenig P., Wohlfart P., Schroeder C., Kummer W.,
RA   Mueller-Esterl W.;
RT   "NOSIP, a novel modulator of endothelial nitric oxide synthase activity.";
RL   FASEB J. 15:79-89(2001).
RN   [21]
RP   INTERACTION WITH NOSTRIN, ACTIVITY REGULATION, AND SUBCELLULAR LOCATION.
RX   PubMed=12446846; DOI=10.1073/pnas.252345399;
RA   Zimmermann K., Opitz N., Dedio J., Renne C., Mueller-Esterl W., Oess S.;
RT   "NOSTRIN: a protein modulating nitric oxide release and subcellular
RT   distribution of endothelial nitric oxide synthase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:17167-17172(2002).
RN   [22]
RP   PHOSPHORYLATION AT THR-495 AND SER-1177.
RX   PubMed=16126727; DOI=10.1074/jbc.m506374200;
RA   David-Dufilho M., Millanvoye-Van Brussel E., Topal G., Walch L., Brunet A.,
RA   Rendu F.;
RT   "Endothelial thrombomodulin induces Ca2+ signals and nitric oxide synthesis
RT   through epidermal growth factor receptor kinase and calmodulin kinase II.";
RL   J. Biol. Chem. 280:35999-36006(2005).
RN   [23]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16234328; DOI=10.1242/jcs.02620;
RA   Icking A., Matt S., Opitz N., Wiesenthal A., Mueller-Esterl W.,
RA   Schilling K.;
RT   "NOSTRIN functions as a homotrimeric adaptor protein facilitating
RT   internalization of eNOS.";
RL   J. Cell Sci. 118:5059-5069(2005).
RN   [24]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16135813; DOI=10.1128/mcb.25.18.8251-8258.2005;
RA   Schleicher M., Brundin F., Gross S., Mueller-Esterl W., Oess S.;
RT   "Cell cycle-regulated inactivation of endothelial NO synthase through
RT   NOSIP-dependent targeting to the cytoskeleton.";
RL   Mol. Cell. Biol. 25:8251-8258(2005).
RN   [25]
RP   PHOSPHORYLATION AT SER-114, AND MUTAGENESIS OF SER-114.
RX   PubMed=20213743; DOI=10.1002/jcb.22515;
RA   Lee C.-H., Wei Y.-W., Huang Y.-T., Lin Y.-T., Lee Y.-C., Lee K.-H.,
RA   Lu P.-J.;
RT   "CDK5 phosphorylates eNOS at Ser-113 and regulates NO production.";
RL   J. Cell. Biochem. 110:112-117(2010).
RN   [26]
RP   INTERACTION WITH HSP90AB1.
RX   PubMed=23585225; DOI=10.1152/ajplung.00419.2012;
RA   Barabutis N., Handa V., Dimitropoulou C., Rafikov R., Snead C., Kumar S.,
RA   Joshi A., Thangjam G., Fulton D., Black S.M., Patel V., Catravas J.D.;
RT   "LPS induces pp60c-src-mediated tyrosine phosphorylation of Hsp90 in lung
RT   vascular endothelial cells and mouse lung.";
RL   Am. J. Physiol. 304:L883-L893(2013).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1177, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-33; SER-633; SER-638 AND
RP   SER-836, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [29]
RP   CATALYTIC ACTIVITY.
RX   PubMed=35772285; DOI=10.1016/j.bmc.2022.116878;
RA   Vasu D., Li H., Hardy C.D., Poulos T.L., Silverman R.B.;
RT   "2-Aminopyridines with a shortened amino sidechain as potent, selective,
RT   and highly permeable human neuronal nitric oxide synthase inhibitors.";
RL   Bioorg. Med. Chem. 69:116878-116878(2022).
RN   [30] {ECO:0007744|PDB:3NOS}
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH
RP   (6R)-L-ERYTHRO-5,6,7,8-TETRAHYDROBIOPTERIN AND ZINC.
RX   PubMed=10074942; DOI=10.1038/6675;
RA   Fischmann T.O., Hruza A., Niu X.D., Fossetta J.D., Lunn C.A., Dolphin E.,
RA   Prongay A.J., Reichert P., Lundell D.J., Narula S.K., Weber P.C.;
RT   "Structural characterization of nitric oxide synthase isoforms reveals
RT   striking active-site conservation.";
RL   Nat. Struct. Biol. 6:233-242(1999).
RN   [31] {ECO:0007744|PDB:1M9J, ECO:0007744|PDB:1M9K, ECO:0007744|PDB:1M9M, ECO:0007744|PDB:1M9Q, ECO:0007744|PDB:1M9R}
RP   X-RAY CRYSTALLOGRAPHY (1.96 ANGSTROMS) OF 67-480 IN COMPLEX WITH HEME B AND
RP   ZINC.
RX   PubMed=12437348; DOI=10.1021/bi026313j;
RA   Rosenfeld R.J., Garcin E.D., Panda K., Andersson G., Aberg A.,
RA   Wallace A.V., Morris G.M., Olson A.J., Stuehr D.J., Tainer J.A.,
RA   Getzoff E.D.;
RT   "Conformational changes in nitric oxide synthases induced by chlorzoxazone
RT   and nitroindazoles: crystallographic and computational analyses of
RT   inhibitor potency.";
RL   Biochemistry 41:13915-13925(2002).
RN   [32] {ECO:0007744|PDB:3EAH}
RP   X-RAY CRYSTALLOGRAPHY (2.44 ANGSTROMS) OF 66-492 IN COMPLEX WITH HEME AND
RP   ZINC.
RX   PubMed=18849972; DOI=10.1038/nchembio.115;
RA   Garcin E.D., Arvai A.S., Rosenfeld R.J., Kroeger M.D., Crane B.R.,
RA   Andersson G., Andrews G., Hamley P.J., Mallinder P.R., Nicholls D.J.,
RA   St-Gallay S.A., Tinker A.C., Gensmantel N.P., Mete A., Cheshire D.R.,
RA   Connolly S., Stuehr D.J., Aberg A., Wallace A.V., Tainer J.A.,
RA   Getzoff E.D.;
RT   "Anchored plasticity opens doors for selective inhibitor design in nitric
RT   oxide synthase.";
RL   Nat. Chem. Biol. 4:700-707(2008).
RN   [33] {ECO:0007744|PDB:4D1O, ECO:0007744|PDB:4D1P}
RP   X-RAY CRYSTALLOGRAPHY (2.03 ANGSTROMS) OF 302-721 IN COMPLEXES WITH
RP   5,6,7,8-TETRAHYDROBIOPTERIN; L-ARGININE; HEME; ZINC AND AN AMINOPYRIDINE
RP   INHIBITOR, AND COFACTOR.
RX   PubMed=25286850; DOI=10.1107/s1399004714017064;
RA   Li H., Jamal J., Plaza C., Pineda S.H., Chreifi G., Jing Q., Cinelli M.A.,
RA   Silverman R.B., Poulos T.L.;
RT   "Structures of human constitutive nitric oxide synthases.";
RL   Acta Crystallogr. D 70:2667-2674(2014).
RN   [34]
RP   VARIANT GLU-298, AND POSSIBLE INVOLVEMENT IN SUSCEPTIBILITY TO CORONARY
RP   SPASM.
RX   PubMed=9737779; DOI=10.1007/s004390050785;
RA   Yoshimura M., Yasue H., Nakayama M., Shimasaki Y., Sumida H., Sugiyama S.,
RA   Kugiyama K., Ogawa H., Ogawa Y., Saito Y., Miyamoto Y., Nakao K.;
RT   "A missense Glu298Asp variant in the endothelial nitric oxide synthase gene
RT   is associated with coronary spasm in the Japanese.";
RL   Hum. Genet. 103:65-69(1998).
RN   [35]
RP   VARIANT GLU-298, AND POSSIBLE INVOLVEMENT IN SUSCEPTIBILITY TO CORONARY
RP   SPASM.
RX   PubMed=11740345; DOI=10.1097/00008571-200112000-00009;
RA   Sofowora G., Dishy V., Xie H.G., Imamura H., Nishimi Y., Morales C.R.,
RA   Morrow J.D., Kim R.B., Stein C.M., Wood A.J.;
RT   "In-vivo effects of Glu298Asp endothelial nitric oxide synthase
RT   polymorphism.";
RL   Pharmacogenetics 11:809-814(2001).
RN   [36]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-474 AND GLN-602.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Produces nitric oxide (NO) which is implicated in vascular
CC       smooth muscle relaxation through a cGMP-mediated signal transduction
CC       pathway (PubMed:1378832). NO mediates vascular endothelial growth
CC       factor (VEGF)-induced angiogenesis in coronary vessels and promotes
CC       blood clotting through the activation of platelets.
CC       {ECO:0000269|PubMed:1378832}.
CC   -!- FUNCTION: [Isoform eNOS13C]: Lacks eNOS activity, dominant-negative
CC       form that may down-regulate eNOS activity by forming heterodimers with
CC       isoform 1.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 L-arginine + 3 NADPH + 4 O2 + H(+) = 2 L-citrulline + 2
CC         nitric oxide + 3 NADP(+) + 4 H2O; Xref=Rhea:RHEA:19897,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16480, ChEBI:CHEBI:32682, ChEBI:CHEBI:57743,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.14.13.39;
CC         Evidence={ECO:0000269|PubMed:1378832, ECO:0000269|PubMed:35772285};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19898;
CC         Evidence={ECO:0000305|PubMed:1378832};
CC   -!- COFACTOR:
CC       Name=heme b; Xref=ChEBI:CHEBI:60344;
CC         Evidence={ECO:0000269|PubMed:25286850};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000250|UniProtKB:P29476};
CC       Note=Binds 1 FAD. {ECO:0000250|UniProtKB:P29476};
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000250|UniProtKB:P35228};
CC       Note=Binds 1 FMN. {ECO:0000250|UniProtKB:P35228};
CC   -!- COFACTOR:
CC       Name=(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin;
CC         Xref=ChEBI:CHEBI:59560; Evidence={ECO:0000269|PubMed:25286850};
CC       Note=Tetrahydrobiopterin (BH4). May stabilize the dimeric form of the
CC       enzyme. {ECO:0000269|PubMed:25286850};
CC   -!- ACTIVITY REGULATION: Stimulated by calcium/calmodulin. Inhibited by
CC       NOSIP and NOSTRIN. {ECO:0000269|PubMed:11149895,
CC       ECO:0000269|PubMed:12446846}.
CC   -!- SUBUNIT: Homodimer. Interacts with NOSIP and NOSTRIN (PubMed:11149895,
CC       PubMed:12446846). Interacts with HSP90AB1 (By similarity)
CC       (PubMed:11149895, PubMed:12446846, PubMed:23585225). Forms a complex
CC       with ASL, ASS1 and SLC7A1; the complex regulates cell-autonomous L-
CC       arginine synthesis and citrulline recycling while channeling
CC       extracellular L-arginine to nitric oxide synthesis pathway (By
CC       similarity). {ECO:0000250|UniProtKB:P70313,
CC       ECO:0000269|PubMed:11149895, ECO:0000269|PubMed:12446846,
CC       ECO:0000269|PubMed:23585225}.
CC   -!- INTERACTION:
CC       P29474; P60709: ACTB; NbExp=3; IntAct=EBI-1391623, EBI-353944;
CC       P29474; P63010-2: AP2B1; NbExp=3; IntAct=EBI-1391623, EBI-11529439;
CC       P29474; Q8N6T3-3: ARFGAP1; NbExp=3; IntAct=EBI-1391623, EBI-10694449;
CC       P29474; Q9Y575-3: ASB3; NbExp=3; IntAct=EBI-1391623, EBI-14199987;
CC       P29474; Q96FT7-4: ASIC4; NbExp=3; IntAct=EBI-1391623, EBI-9089489;
CC       P29474; Q5SZD1: C6orf141; NbExp=3; IntAct=EBI-1391623, EBI-10697767;
CC       P29474; Q16543: CDC37; NbExp=4; IntAct=EBI-1391623, EBI-295634;
CC       P29474; Q9UNS2: COPS3; NbExp=3; IntAct=EBI-1391623, EBI-350590;
CC       P29474; Q8IUI8: CRLF3; NbExp=3; IntAct=EBI-1391623, EBI-2872414;
CC       P29474; P35222: CTNNB1; NbExp=4; IntAct=EBI-1391623, EBI-491549;
CC       P29474; Q05193: DNM1; NbExp=2; IntAct=EBI-1391623, EBI-713135;
CC       P29474; O15287: FANCG; NbExp=3; IntAct=EBI-1391623, EBI-81610;
CC       P29474; Q08379: GOLGA2; NbExp=6; IntAct=EBI-1391623, EBI-618309;
CC       P29474; Q71DI3: H3C15; NbExp=3; IntAct=EBI-1391623, EBI-750650;
CC       P29474; P69905: HBA2; NbExp=2; IntAct=EBI-1391623, EBI-714680;
CC       P29474; P61978: HNRNPK; NbExp=3; IntAct=EBI-1391623, EBI-304185;
CC       P29474; Q12891: HYAL2; NbExp=3; IntAct=EBI-1391623, EBI-2806068;
CC       P29474; Q9UKT9: IKZF3; NbExp=3; IntAct=EBI-1391623, EBI-747204;
CC       P29474; Q9Y2M5: KLHL20; NbExp=3; IntAct=EBI-1391623, EBI-714379;
CC       P29474; Q14525: KRT33B; NbExp=3; IntAct=EBI-1391623, EBI-1049638;
CC       P29474; Q6DKI2: LGALS9C; NbExp=3; IntAct=EBI-1391623, EBI-9088829;
CC       P29474; P43364-2: MAGEA11; NbExp=3; IntAct=EBI-1391623, EBI-10178634;
CC       P29474; Q8N6F8: METTL27; NbExp=3; IntAct=EBI-1391623, EBI-8487781;
CC       P29474; O94851: MICAL2; NbExp=3; IntAct=EBI-1391623, EBI-2804835;
CC       P29474; A4FUJ8: MKL1; NbExp=3; IntAct=EBI-1391623, EBI-21250407;
CC       P29474; Q8N594: MPND; NbExp=3; IntAct=EBI-1391623, EBI-2512452;
CC       P29474; Q8IVI9: NOSTRIN; NbExp=9; IntAct=EBI-1391623, EBI-1391643;
CC       P29474; Q6X4W1-6: NSMF; NbExp=3; IntAct=EBI-1391623, EBI-25842707;
CC       P29474; O15381-5: NVL; NbExp=3; IntAct=EBI-1391623, EBI-18577082;
CC       P29474; Q9NV79: PCMTD2; NbExp=3; IntAct=EBI-1391623, EBI-6309018;
CC       P29474; Q16549: PCSK7; NbExp=3; IntAct=EBI-1391623, EBI-8059854;
CC       P29474; Q5T2W1: PDZK1; NbExp=3; IntAct=EBI-1391623, EBI-349819;
CC       P29474; O75925: PIAS1; NbExp=3; IntAct=EBI-1391623, EBI-629434;
CC       P29474; Q96I34: PPP1R16A; NbExp=3; IntAct=EBI-1391623, EBI-710402;
CC       P29474; Q6ZMI0-5: PPP1R21; NbExp=3; IntAct=EBI-1391623, EBI-25835994;
CC       P29474; P57052: RBM11; NbExp=3; IntAct=EBI-1391623, EBI-741332;
CC       P29474; Q9GZR2: REXO4; NbExp=3; IntAct=EBI-1391623, EBI-2856313;
CC       P29474; Q96D59: RNF183; NbExp=3; IntAct=EBI-1391623, EBI-743938;
CC       P29474; Q8N6K7-2: SAMD3; NbExp=3; IntAct=EBI-1391623, EBI-11528848;
CC       P29474; Q9GZS3: SKIC8; NbExp=3; IntAct=EBI-1391623, EBI-358545;
CC       P29474; Q8IUW3: SPATA2L; NbExp=3; IntAct=EBI-1391623, EBI-2510414;
CC       P29474; Q7Z699: SPRED1; NbExp=3; IntAct=EBI-1391623, EBI-5235340;
CC       P29474; Q7Z698: SPRED2; NbExp=3; IntAct=EBI-1391623, EBI-7082156;
CC       P29474; P50502: ST13; NbExp=3; IntAct=EBI-1391623, EBI-357285;
CC       P29474; Q9BR01-2: SULT4A1; NbExp=3; IntAct=EBI-1391623, EBI-25831443;
CC       P29474; Q9NVV9: THAP1; NbExp=3; IntAct=EBI-1391623, EBI-741515;
CC       P29474; Q86WT6-2: TRIM69; NbExp=3; IntAct=EBI-1391623, EBI-11525489;
CC       P29474; Q9H347: UBQLN3; NbExp=3; IntAct=EBI-1391623, EBI-25832660;
CC       P29474; P58304: VSX2; NbExp=3; IntAct=EBI-1391623, EBI-6427899;
CC       P29474; Q9NZC7-5: WWOX; NbExp=3; IntAct=EBI-1391623, EBI-12040603;
CC       P29474; Q9UNY5: ZNF232; NbExp=3; IntAct=EBI-1391623, EBI-749023;
CC       P29474; P14079: tax; Xeno; NbExp=3; IntAct=EBI-1391623, EBI-9675698;
CC   -!- SUBCELLULAR LOCATION: Cell membrane. Membrane, caveola. Cytoplasm,
CC       cytoskeleton. Golgi apparatus. Note=Specifically associates with actin
CC       cytoskeleton in the G2 phase of the cell cycle; which is favored by
CC       interaction with NOSIP and results in a reduced enzymatic activity.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P29474-1; Sequence=Displayed;
CC       Name=eNOS13C;
CC         IsoId=P29474-2; Sequence=VSP_042625, VSP_042626;
CC       Name=eNOS13B;
CC         IsoId=P29474-3; Sequence=VSP_045495, VSP_045496;
CC   -!- TISSUE SPECIFICITY: Platelets, placenta, liver and kidney.
CC       {ECO:0000269|PubMed:7515611}.
CC   -!- PTM: Phosphorylation by AMPK at Ser-1177 in the presence of Ca(2+)-
CC       calmodulin (CaM) activates activity. In absence of Ca(2+)-calmodulin,
CC       AMPK also phosphorylates Thr-495, resulting in inhibition of activity
CC       (By similarity). Phosphorylation of Ser-114 by CDK5 reduces activity.
CC       {ECO:0000250, ECO:0000269|PubMed:16126727,
CC       ECO:0000269|PubMed:20213743}.
CC   -!- DISEASE: Note=Variation Asp-298 in NOS3 may be associated with
CC       susceptibility to coronary spasm. {ECO:0000269|PubMed:11740345,
CC       ECO:0000269|PubMed:9737779}.
CC   -!- MISCELLANEOUS: [Isoform eNOS13C]: Lacks eNOS activity. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the NOS family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Nitric oxide synthase entry;
CC       URL="https://en.wikipedia.org/wiki/Nitric_oxide_synthase";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M93718; AAA36364.1; -; mRNA.
DR   EMBL; M95296; AAA36372.1; -; mRNA.
DR   EMBL; L10709; AAA36365.1; -; Genomic_DNA.
DR   EMBL; L10693; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10694; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10695; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10696; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10697; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10698; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10699; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10700; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10701; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10702; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10703; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10704; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10705; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10706; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10707; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10708; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; X76303; CAA53950.1; -; Genomic_DNA.
DR   EMBL; X76304; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76305; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76306; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76307; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76308; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76309; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76310; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76311; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76312; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76313; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76314; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76315; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76316; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; D26607; BAA05652.1; -; Genomic_DNA.
DR   EMBL; DQ256130; ABB79839.1; -; mRNA.
DR   EMBL; DQ256131; ABB79840.1; -; mRNA.
DR   EMBL; L26914; AAA36374.1; -; Genomic_DNA.
DR   EMBL; AF400594; AAK83389.1; -; mRNA.
DR   EMBL; AK292928; BAF85617.1; -; mRNA.
DR   EMBL; AK315213; BAG37648.1; -; mRNA.
DR   EMBL; AK223636; BAD97356.1; -; mRNA.
DR   EMBL; AF519768; AAM74944.1; -; Genomic_DNA.
DR   EMBL; EU332855; ABY87544.1; -; Genomic_DNA.
DR   EMBL; AC010973; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471173; EAW54069.1; -; Genomic_DNA.
DR   EMBL; BC063294; AAH63294.1; -; mRNA.
DR   EMBL; BC069465; AAH69465.1; -; mRNA.
DR   EMBL; L23210; AAA36373.1; -; Genomic_DNA.
DR   EMBL; S80791; AAD14336.1; -; mRNA.
DR   CCDS; CCDS55182.1; -. [P29474-2]
DR   CCDS; CCDS55183.1; -. [P29474-3]
DR   CCDS; CCDS5912.1; -. [P29474-1]
DR   PIR; A47501; A47501.
DR   RefSeq; NP_000594.2; NM_000603.4. [P29474-1]
DR   RefSeq; NP_001153581.1; NM_001160109.1.
DR   RefSeq; NP_001153582.1; NM_001160110.1. [P29474-3]
DR   RefSeq; NP_001153583.1; NM_001160111.1. [P29474-2]
DR   RefSeq; XP_016867721.1; XM_017012232.1.
DR   PDB; 1M9J; X-ray; 2.43 A; A/B=67-481.
DR   PDB; 1M9K; X-ray; 2.01 A; A/B=67-481.
DR   PDB; 1M9M; X-ray; 1.96 A; A/B=67-481.
DR   PDB; 1M9Q; X-ray; 2.01 A; A/B=67-481.
DR   PDB; 1M9R; X-ray; 2.56 A; A/B=67-481.
DR   PDB; 1NIW; X-ray; 2.05 A; B/D/F/H=492-511.
DR   PDB; 2LL7; NMR; -; B=493-509.
DR   PDB; 2MG5; NMR; -; B=495-510.
DR   PDB; 2N8J; NMR; -; B=491-512.
DR   PDB; 3EAH; X-ray; 2.44 A; A/B=66-492.
DR   PDB; 3NOS; X-ray; 2.40 A; A/B=66-492.
DR   PDB; 4D1O; X-ray; 1.82 A; A/B=41-480.
DR   PDB; 4D1P; X-ray; 1.73 A; A/B=41-480.
DR   PDB; 5UO8; X-ray; 2.18 A; A/B/C/D=41-480.
DR   PDB; 5UO9; X-ray; 2.19 A; A/B/C/D=41-480.
DR   PDB; 5UOA; X-ray; 2.20 A; A/B=41-480.
DR   PDB; 5UOB; X-ray; 2.29 A; A/B/C/D=41-480.
DR   PDB; 5UOC; X-ray; 2.20 A; A/B/C/D=41-480.
DR   PDB; 5VVB; X-ray; 2.15 A; A/B/C/D=41-480.
DR   PDB; 5VVC; X-ray; 2.40 A; A/B/C/D=41-480.
DR   PDB; 5VVD; X-ray; 2.25 A; A/B/C/D=41-480.
DR   PDB; 5XOF; X-ray; 1.96 A; O/P/Q/R=30-36.
DR   PDB; 6AV6; X-ray; 2.08 A; A/B/C/D=41-480.
DR   PDB; 6AV7; X-ray; 1.92 A; A/B/C/D=41-480.
DR   PDB; 6CIE; X-ray; 1.95 A; A/B/C/D=41-480.
DR   PDB; 6CIF; X-ray; 2.20 A; A/B/C/D=41-480.
DR   PDB; 6NH1; X-ray; 2.22 A; A/B/C/D=41-480.
DR   PDB; 6NH2; X-ray; 2.29 A; A/B/C/D=41-480.
DR   PDB; 6NH3; X-ray; 2.01 A; A/B/C/D=41-480.
DR   PDB; 6NH4; X-ray; 2.27 A; A/B/C/D=41-480.
DR   PDB; 6NH5; X-ray; 1.96 A; A/B/C/D=41-480.
DR   PDB; 6NH6; X-ray; 2.19 A; A/B/C/D=41-480.
DR   PDB; 6NH7; X-ray; 1.90 A; A/B=41-480.
DR   PDB; 6NH8; X-ray; 1.80 A; A/B/C/D=41-480.
DR   PDB; 6NHF; X-ray; 1.83 A; A/B/C/D=41-480.
DR   PDB; 6POU; X-ray; 2.19 A; A/B/C/D/E/F=41-480.
DR   PDB; 6POV; X-ray; 2.05 A; A/B/C/D=41-480.
DR   PDB; 6POW; X-ray; 2.15 A; A/B/C/D=41-480.
DR   PDB; 6POX; X-ray; 2.20 A; A/B/C/D=41-480.
DR   PDB; 6POY; X-ray; 2.30 A; A/B/C/D=41-480.
DR   PDB; 6POZ; X-ray; 2.20 A; A/B/C/D=41-480.
DR   PDB; 6PP0; X-ray; 1.97 A; A/B/C/D=41-480.
DR   PDB; 6PP1; X-ray; 1.76 A; A/B/C/D=41-480.
DR   PDB; 6PP2; X-ray; 2.02 A; A/B/C/D=41-480.
DR   PDB; 6PP3; X-ray; 1.95 A; A/B/C/D=41-480.
DR   PDB; 6PP4; X-ray; 2.20 A; A/B/C/D=41-480.
DR   PDB; 7M56; X-ray; 1.96 A; A/B=41-480.
DR   PDB; 7TSG; X-ray; 1.85 A; A/B/C/D=41-480.
DR   PDB; 7TSH; X-ray; 2.15 A; A/B/C/D=41-480.
DR   PDB; 7TSI; X-ray; 2.10 A; A/B/C/D=41-480.
DR   PDB; 7TSK; X-ray; 2.05 A; A/B/C/D=41-480.
DR   PDB; 7TSL; X-ray; 1.90 A; A/B/C/D=41-480.
DR   PDB; 7TSM; X-ray; 1.85 A; A/B/C/D=41-480.
DR   PDB; 7TSN; X-ray; 2.08 A; A/B/C/D=41-480.
DR   PDB; 7TSO; X-ray; 2.00 A; A/B/C/D=41-480.
DR   PDB; 7TSP; X-ray; 2.00 A; A/B/C/D=41-480.
DR   PDB; 7UAO; X-ray; 1.90 A; A/B/C/D=41-480.
DR   PDB; 8FGN; X-ray; 2.20 A; A/B/C/D=41-480.
DR   PDB; 8FGO; X-ray; 1.80 A; A/B/C/D=41-480.
DR   PDB; 8FGP; X-ray; 1.88 A; A/B/C/D=41-480.
DR   PDB; 8FGQ; X-ray; 2.20 A; A/B/C/D=41-480.
DR   PDB; 8FGR; X-ray; 1.98 A; A/B/C/D=41-480.
DR   PDB; 8FGS; X-ray; 1.84 A; A/B/C/D=41-480.
DR   PDB; 8FGT; X-ray; 1.90 A; A/B/C/D=41-480.
DR   PDB; 8FGU; X-ray; 2.00 A; A/B/C/D=41-480.
DR   PDB; 8UFR; X-ray; 1.87 A; A/B/C/D=41-480.
DR   PDB; 8UFS; X-ray; 2.05 A; A/B/C/D=41-480.
DR   PDB; 8UFT; X-ray; 1.78 A; A/B/C/D=41-480.
DR   PDB; 8UFU; X-ray; 2.05 A; A/B/C/D=41-480.
DR   PDBsum; 1M9J; -.
DR   PDBsum; 1M9K; -.
DR   PDBsum; 1M9M; -.
DR   PDBsum; 1M9Q; -.
DR   PDBsum; 1M9R; -.
DR   PDBsum; 1NIW; -.
DR   PDBsum; 2LL7; -.
DR   PDBsum; 2MG5; -.
DR   PDBsum; 2N8J; -.
DR   PDBsum; 3EAH; -.
DR   PDBsum; 3NOS; -.
DR   PDBsum; 4D1O; -.
DR   PDBsum; 4D1P; -.
DR   PDBsum; 5UO8; -.
DR   PDBsum; 5UO9; -.
DR   PDBsum; 5UOA; -.
DR   PDBsum; 5UOB; -.
DR   PDBsum; 5UOC; -.
DR   PDBsum; 5VVB; -.
DR   PDBsum; 5VVC; -.
DR   PDBsum; 5VVD; -.
DR   PDBsum; 5XOF; -.
DR   PDBsum; 6AV6; -.
DR   PDBsum; 6AV7; -.
DR   PDBsum; 6CIE; -.
DR   PDBsum; 6CIF; -.
DR   PDBsum; 6NH1; -.
DR   PDBsum; 6NH2; -.
DR   PDBsum; 6NH3; -.
DR   PDBsum; 6NH4; -.
DR   PDBsum; 6NH5; -.
DR   PDBsum; 6NH6; -.
DR   PDBsum; 6NH7; -.
DR   PDBsum; 6NH8; -.
DR   PDBsum; 6NHF; -.
DR   PDBsum; 6POU; -.
DR   PDBsum; 6POV; -.
DR   PDBsum; 6POW; -.
DR   PDBsum; 6POX; -.
DR   PDBsum; 6POY; -.
DR   PDBsum; 6POZ; -.
DR   PDBsum; 6PP0; -.
DR   PDBsum; 6PP1; -.
DR   PDBsum; 6PP2; -.
DR   PDBsum; 6PP3; -.
DR   PDBsum; 6PP4; -.
DR   PDBsum; 7M56; -.
DR   PDBsum; 7TSG; -.
DR   PDBsum; 7TSH; -.
DR   PDBsum; 7TSI; -.
DR   PDBsum; 7TSK; -.
DR   PDBsum; 7TSL; -.
DR   PDBsum; 7TSM; -.
DR   PDBsum; 7TSN; -.
DR   PDBsum; 7TSO; -.
DR   PDBsum; 7TSP; -.
DR   PDBsum; 7UAO; -.
DR   PDBsum; 8FGN; -.
DR   PDBsum; 8FGO; -.
DR   PDBsum; 8FGP; -.
DR   PDBsum; 8FGQ; -.
DR   PDBsum; 8FGR; -.
DR   PDBsum; 8FGS; -.
DR   PDBsum; 8FGT; -.
DR   PDBsum; 8FGU; -.
DR   PDBsum; 8UFR; -.
DR   PDBsum; 8UFS; -.
DR   PDBsum; 8UFT; -.
DR   PDBsum; 8UFU; -.
DR   AlphaFoldDB; P29474; -.
DR   BMRB; P29474; -.
DR   SMR; P29474; -.
DR   BioGRID; 110909; 52.
DR   CORUM; P29474; -.
DR   DIP; DIP-38479N; -.
DR   FunCoup; P29474; 1261.
DR   IntAct; P29474; 80.
DR   MINT; P29474; -.
DR   STRING; 9606.ENSP00000297494; -.
DR   BindingDB; P29474; -.
DR   ChEMBL; CHEMBL4803; -.
DR   DrugBank; DB07001; (3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine.
DR   DrugBank; DB02048; 1,2,4-Triazole-Carboxamidine.
DR   DrugBank; DB02911; 2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine.
DR   DrugBank; DB02335; 2-Aminothiazoline.
DR   DrugBank; DB01997; 3-Bromo-7-Nitroindazole.
DR   DrugBank; DB03332; 5,6-Cyclic-Tetrahydropteridine.
DR   DrugBank; DB04534; 5-Nitroindazole.
DR   DrugBank; DB07244; 5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE.
DR   DrugBank; DB03100; 6-Nitroindazole.
DR   DrugBank; DB03918; 6S-5,6,7,8-Tetrahydrobiopterin.
DR   DrugBank; DB02207; 7-Nitroindazole.
DR   DrugBank; DB03065; 7-Nitroindazole-2-Carboxamidine.
DR   DrugBank; DB14511; Acetate.
DR   DrugBank; DB00125; Arginine.
DR   DrugBank; DB02994; Cacodylic acid.
DR   DrugBank; DB01833; Canavanine.
DR   DrugBank; DB00155; Citrulline.
DR   DrugBank; DB00997; Doxorubicin.
DR   DrugBank; DB07388; ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE.
DR   DrugBank; DB05252; Fenoxaprop-ethyl.
DR   DrugBank; DB18267; Ferroheme.
DR   DrugBank; DB02325; Isopropyl alcohol.
DR   DrugBank; DB03974; L-homoarginine.
DR   DrugBank; DB02077; L-N(omega)-nitroarginine-(4R)-amino-L-proline amide.
DR   DrugBank; DB01821; L-N(omega)-Nitroarginine-2,4-L-diaminobutyric amide.
DR   DrugBank; DB09237; Levamlodipine.
DR   DrugBank; DB01110; Miconazole.
DR   DrugBank; DB03144; N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine.
DR   DrugBank; DB03305; N(G)-Iminoethylornithine.
DR   DrugBank; DB01686; N,N-dimethylarginine.
DR   DrugBank; DB04559; N-(Chlorophenyl)-N'-hydroxyguanidine.
DR   DrugBank; DB02044; N-[3-(aminomethyl)benzyl]acetamidine.
DR   DrugBank; DB12750; N-omega-nitro-L-arginine methyl ester.
DR   DrugBank; DB08019; N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine.
DR   DrugBank; DB08018; N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE.
DR   DrugBank; DB02027; N-{(4S)-4-Amino-5-[(2-aminoethyl)amino]pentyl}-N'-nitroguanidine.
DR   DrugBank; DB02979; N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane.
DR   DrugBank; DB00435; Nitric Oxide.
DR   DrugBank; DB04223; Nitroarginine.
DR   DrugBank; DB06154; Pentaerythritol tetranitrate.
DR   DrugBank; DB03910; S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea.
DR   DrugBank; DB02141; S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea.
DR   DrugBank; DB03963; S-(Dimethylarsenic)Cysteine.
DR   DrugBank; DB03707; S-Ethyl-N-Phenyl-Isothiourea.
DR   DrugBank; DB02234; S-Ethylisothiourea.
DR   DrugBank; DB04018; S-Isopropyl-Isothiourea.
DR   DrugBank; DB00360; Sapropterin.
DR   DrugBank; DB02589; Se-Ethyl-Isoselenourea.
DR   DrugBank; DB11815; Tilarginine.
DR   DrugCentral; P29474; -.
DR   GuidetoPHARMACOLOGY; 1249; -.
DR   GlyCosmos; P29474; 1 site, 1 glycan.
DR   GlyGen; P29474; 8 sites, 2 O-linked glycans (4 sites).
DR   iPTMnet; P29474; -.
DR   PhosphoSitePlus; P29474; -.
DR   SwissPalm; P29474; -.
DR   BioMuta; NOS3; -.
DR   DMDM; 266648; -.
DR   jPOST; P29474; -.
DR   MassIVE; P29474; -.
DR   PaxDb; 9606-ENSP00000297494; -.
DR   PeptideAtlas; P29474; -.
DR   ProteomicsDB; 20158; -.
DR   ProteomicsDB; 54576; -. [P29474-1]
DR   ProteomicsDB; 54577; -. [P29474-2]
DR   Antibodypedia; 3692; 1678 antibodies from 44 providers.
DR   DNASU; 4846; -.
DR   Ensembl; ENST00000297494.8; ENSP00000297494.3; ENSG00000164867.11. [P29474-1]
DR   Ensembl; ENST00000467517.1; ENSP00000420551.1; ENSG00000164867.11. [P29474-3]
DR   Ensembl; ENST00000484524.5; ENSP00000420215.1; ENSG00000164867.11. [P29474-2]
DR   GeneID; 4846; -.
DR   KEGG; hsa:4846; -.
DR   MANE-Select; ENST00000297494.8; ENSP00000297494.3; NM_000603.5; NP_000594.2.
DR   UCSC; uc003wif.4; human. [P29474-1]
DR   AGR; HGNC:7876; -.
DR   CTD; 4846; -.
DR   DisGeNET; 4846; -.
DR   GeneCards; NOS3; -.
DR   HGNC; HGNC:7876; NOS3.
DR   HPA; ENSG00000164867; Tissue enhanced (lymphoid).
DR   MalaCards; NOS3; -.
DR   MIM; 163729; gene+phenotype.
DR   OpenTargets; ENSG00000164867; -.
DR   VEuPathDB; HostDB:ENSG00000164867; -.
DR   eggNOG; KOG1158; Eukaryota.
DR   GeneTree; ENSGT00940000161389; -.
DR   InParanoid; P29474; -.
DR   OMA; KGDFRIW; -.
DR   OrthoDB; 1856718at2759; -.
DR   PAN-GO; P29474; 14 GO annotations based on evolutionary models.
DR   PhylomeDB; P29474; -.
DR   BioCyc; MetaCyc:HS09149-MONOMER; -.
DR   BRENDA; 1.14.13.39; 2681.
DR   PathwayCommons; P29474; -.
DR   Reactome; R-HSA-1222556; ROS and RNS production in phagocytes.
DR   Reactome; R-HSA-1474151; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation.
DR   Reactome; R-HSA-203615; eNOS activation.
DR   Reactome; R-HSA-203641; NOSTRIN mediated eNOS trafficking.
DR   Reactome; R-HSA-203754; NOSIP mediated eNOS trafficking.
DR   Reactome; R-HSA-392154; Nitric oxide stimulates guanylate cyclase.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-9009391; Extra-nuclear estrogen signaling.
DR   Reactome; R-HSA-9856530; High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells.
DR   SignaLink; P29474; -.
DR   SIGNOR; P29474; -.
DR   BioGRID-ORCS; 4846; 8 hits in 1170 CRISPR screens.
DR   ChiTaRS; NOS3; human.
DR   EvolutionaryTrace; P29474; -.
DR   GeneWiki; Endothelial_NOS; -.
DR   GenomeRNAi; 4846; -.
DR   Pharos; P29474; Tchem.
DR   PRO; PR:P29474; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; P29474; protein.
DR   Bgee; ENSG00000164867; Expressed in spleen and 97 other cell types or tissues.
DR   ExpressionAtlas; P29474; baseline and differential.
DR   GO; GO:0005901; C:caveola; IDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0030666; C:endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:BHF-UCL.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0003785; F:actin monomer binding; IPI:BHF-UCL.
DR   GO; GO:0034618; F:arginine binding; IDA:BHF-UCL.
DR   GO; GO:0046870; F:cadmium ion binding; NAS:BHF-UCL.
DR   GO; GO:0005516; F:calmodulin binding; EXP:Reactome.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IBA:GO_Central.
DR   GO; GO:0010181; F:FMN binding; IBA:GO_Central.
DR   GO; GO:0020037; F:heme binding; IDA:BHF-UCL.
DR   GO; GO:0050661; F:NADP binding; NAS:BHF-UCL.
DR   GO; GO:0004517; F:nitric-oxide synthase activity; IDA:UniProtKB.
DR   GO; GO:0097110; F:scaffold protein binding; IEA:Ensembl.
DR   GO; GO:0016175; F:superoxide-generating NAD(P)H oxidase activity; TAS:Reactome.
DR   GO; GO:0034617; F:tetrahydrobiopterin binding; IDA:BHF-UCL.
DR   GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
DR   GO; GO:0003180; P:aortic valve morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0006527; P:arginine catabolic process; IDA:BHF-UCL.
DR   GO; GO:0097746; P:blood vessel diameter maintenance; ISS:BHF-UCL.
DR   GO; GO:0001974; P:blood vessel remodeling; ISS:BHF-UCL.
DR   GO; GO:0006816; P:calcium ion transport; IEA:Ensembl.
DR   GO; GO:0045454; P:cell redox homeostasis; TAS:Reactome.
DR   GO; GO:0003203; P:endocardial cushion morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0043542; P:endothelial cell migration; IMP:BHF-UCL.
DR   GO; GO:0051649; P:establishment of localization in cell; IEA:Ensembl.
DR   GO; GO:0048873; P:homeostasis of number of cells within a tissue; ISS:BHF-UCL.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0007005; P:mitochondrion organization; ISS:BHF-UCL.
DR   GO; GO:0070168; P:negative regulation of biomineral tissue development; ISS:BHF-UCL.
DR   GO; GO:0045776; P:negative regulation of blood pressure; IBA:GO_Central.
DR   GO; GO:0051926; P:negative regulation of calcium ion transport; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:BHF-UCL.
DR   GO; GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; ISS:BHF-UCL.
DR   GO; GO:0014740; P:negative regulation of muscle hyperplasia; ISS:BHF-UCL.
DR   GO; GO:0010544; P:negative regulation of platelet activation; NAS:BHF-UCL.
DR   GO; GO:0043267; P:negative regulation of potassium ion transport; IEA:Ensembl.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0006809; P:nitric oxide biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0007263; P:nitric oxide mediated signal transduction; IBA:GO_Central.
DR   GO; GO:0046209; P:nitric oxide metabolic process; TAS:Reactome.
DR   GO; GO:0001542; P:ovulation from ovarian follicle; IEA:Ensembl.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IDA:BHF-UCL.
DR   GO; GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IDA:BHF-UCL.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISS:BHF-UCL.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IC:BHF-UCL.
DR   GO; GO:0006813; P:potassium ion transport; IEA:Ensembl.
DR   GO; GO:0003184; P:pulmonary valve morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0008217; P:regulation of blood pressure; NAS:BHF-UCL.
DR   GO; GO:0031644; P:regulation of nervous system process; ISS:ARUK-UCL.
DR   GO; GO:0002028; P:regulation of sodium ion transport; IEA:Ensembl.
DR   GO; GO:0003100; P:regulation of systemic arterial blood pressure by endothelin; IMP:BHF-UCL.
DR   GO; GO:0003057; P:regulation of the force of heart contraction by chemical signal; IEA:Ensembl.
DR   GO; GO:0019430; P:removal of superoxide radicals; IDA:BHF-UCL.
DR   GO; GO:0034405; P:response to fluid shear stress; IEP:BHF-UCL.
DR   GO; GO:0009408; P:response to heat; NAS:BHF-UCL.
DR   GO; GO:0009725; P:response to hormone; IBA:GO_Central.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IBA:GO_Central.
DR   GO; GO:0014806; P:smooth muscle hyperplasia; ISS:BHF-UCL.
DR   GO; GO:0046146; P:tetrahydrobiopterin metabolic process; TAS:Reactome.
DR   GO; GO:0042311; P:vasodilation; NAS:BHF-UCL.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; IEA:Ensembl.
DR   CDD; cd00795; NOS_oxygenase_euk; 1.
DR   FunFam; 3.90.440.10:FF:000001; Endothelial nitric oxide synthase; 1.
DR   FunFam; 1.20.990.10:FF:000005; Nitric oxide synthase; 1.
DR   FunFam; 3.40.50.360:FF:000003; Nitric oxide synthase; 1.
DR   FunFam; 3.40.50.80:FF:000003; Nitric oxide synthase; 1.
DR   FunFam; 3.90.1230.10:FF:000001; Nitric oxide synthase, brain; 1.
DR   Gene3D; 3.40.50.360; -; 1.
DR   Gene3D; 1.20.990.10; NADPH-cytochrome p450 Reductase, Chain A, domain 3; 1.
DR   Gene3D; 3.90.340.10; Nitric Oxide Synthase, Chain A, domain 1; 1.
DR   Gene3D; 3.90.1230.10; Nitric Oxide Synthase, Chain A, domain 3; 1.
DR   Gene3D; 3.90.440.10; Nitric Oxide Synthase,Heme Domain,Chain A domain 2; 1.
DR   Gene3D; 3.40.50.80; Nucleotide-binding domain of ferredoxin-NADP reductase (FNR) module; 1.
DR   Gene3D; 2.40.30.10; Translation factors; 1.
DR   InterPro; IPR003097; CysJ-like_FAD-binding.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR001094; Flavdoxin-like.
DR   InterPro; IPR008254; Flavodoxin/NO_synth.
DR   InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR   InterPro; IPR029039; Flavoprotein-like_sf.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR023173; NADPH_Cyt_P450_Rdtase_alpha.
DR   InterPro; IPR050607; NOS.
DR   InterPro; IPR044943; NOS_dom_1.
DR   InterPro; IPR044940; NOS_dom_2.
DR   InterPro; IPR044944; NOS_dom_3.
DR   InterPro; IPR012144; NOS_euk.
DR   InterPro; IPR004030; NOS_N.
DR   InterPro; IPR036119; NOS_N_sf.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   PANTHER; PTHR43410:SF1; NITRIC OXIDE SYNTHASE; 1.
DR   PANTHER; PTHR43410; NITRIC OXIDE SYNTHASE OXYGENASE; 1.
DR   Pfam; PF00667; FAD_binding_1; 1.
DR   Pfam; PF00258; Flavodoxin_1; 1.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   Pfam; PF02898; NO_synthase; 1.
DR   PIRSF; PIRSF000333; NOS; 1.
DR   PRINTS; PR00369; FLAVODOXIN.
DR   PRINTS; PR00371; FPNCR.
DR   SUPFAM; SSF52343; Ferredoxin reductase-like, C-terminal NADP-linked domain; 1.
DR   SUPFAM; SSF52218; Flavoproteins; 1.
DR   SUPFAM; SSF56512; Nitric oxide (NO) synthase oxygenase domain; 1.
DR   SUPFAM; SSF63380; Riboflavin synthase domain-like; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
DR   PROSITE; PS50902; FLAVODOXIN_LIKE; 1.
DR   PROSITE; PS60001; NOS; 1.
DR   neXtProt; NX_P29474; -.
DR   PharmGKB; PA254; -.
DR   TreeFam; TF324410; -.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Calmodulin-binding;
KW   Cell membrane; Cytoplasm; Cytoskeleton; Direct protein sequencing; FAD;
KW   Flavoprotein; FMN; Golgi apparatus; Heme; Iron; Lipoprotein; Membrane;
KW   Metal-binding; Myristate; NADP; Oxidoreductase; Palmitate; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Zinc.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P29473"
FT   CHAIN           2..1203
FT                   /note="Nitric oxide synthase 3"
FT                   /id="PRO_0000170943"
FT   DOMAIN          520..703
FT                   /note="Flavodoxin-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00088"
FT   DOMAIN          756..1002
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT   REGION          1..71
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          98..486
FT                   /note="Interaction with NOSIP"
FT                   /evidence="ECO:0000269|PubMed:11149895"
FT   REGION          491..510
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        15..27
FT                   /note="Gly residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        33..66
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         94
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="ligand shared between homodimeric partners"
FT                   /evidence="ECO:0000269|PubMed:10074942,
FT                   ECO:0000269|PubMed:12437348, ECO:0000269|PubMed:18849972,
FT                   ECO:0000269|PubMed:25286850, ECO:0007744|PDB:1M9J,
FT                   ECO:0007744|PDB:1M9K, ECO:0007744|PDB:1M9M,
FT                   ECO:0007744|PDB:1M9Q, ECO:0007744|PDB:1M9R,
FT                   ECO:0007744|PDB:3EAH, ECO:0007744|PDB:3NOS,
FT                   ECO:0007744|PDB:4D1O, ECO:0007744|PDB:4D1P"
FT   BINDING         99
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="ligand shared between homodimeric partners"
FT                   /evidence="ECO:0000269|PubMed:10074942,
FT                   ECO:0000269|PubMed:12437348, ECO:0000269|PubMed:18849972,
FT                   ECO:0000269|PubMed:25286850, ECO:0007744|PDB:1M9J,
FT                   ECO:0007744|PDB:1M9K, ECO:0007744|PDB:1M9M,
FT                   ECO:0007744|PDB:1M9Q, ECO:0007744|PDB:1M9R,
FT                   ECO:0007744|PDB:3EAH, ECO:0007744|PDB:3NOS,
FT                   ECO:0007744|PDB:4D1O, ECO:0007744|PDB:4D1P"
FT   BINDING         102
FT                   /ligand="(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin"
FT                   /ligand_id="ChEBI:CHEBI:59560"
FT                   /evidence="ECO:0000269|PubMed:25286850,
FT                   ECO:0007744|PDB:4D1O"
FT   BINDING         184
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000269|PubMed:25286850,
FT                   ECO:0007744|PDB:4D1O"
FT   BINDING         247
FT                   /ligand="L-arginine"
FT                   /ligand_id="ChEBI:CHEBI:32682"
FT                   /evidence="ECO:0000269|PubMed:25286850,
FT                   ECO:0007744|PDB:4D1O"
FT   BINDING         356
FT                   /ligand="L-arginine"
FT                   /ligand_id="ChEBI:CHEBI:32682"
FT                   /evidence="ECO:0000269|PubMed:25286850,
FT                   ECO:0007744|PDB:4D1O"
FT   BINDING         357
FT                   /ligand="L-arginine"
FT                   /ligand_id="ChEBI:CHEBI:32682"
FT                   /evidence="ECO:0000269|PubMed:25286850,
FT                   ECO:0007744|PDB:4D1O"
FT   BINDING         361
FT                   /ligand="L-arginine"
FT                   /ligand_id="ChEBI:CHEBI:32682"
FT                   /evidence="ECO:0000269|PubMed:25286850,
FT                   ECO:0007744|PDB:4D1O"
FT   BINDING         365
FT                   /ligand="(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin"
FT                   /ligand_id="ChEBI:CHEBI:59560"
FT                   /evidence="ECO:0000269|PubMed:10074942,
FT                   ECO:0000269|PubMed:25286850, ECO:0007744|PDB:3NOS,
FT                   ECO:0007744|PDB:4D1O, ECO:0007744|PDB:4D1P"
FT   BINDING         366
FT                   /ligand="L-arginine"
FT                   /ligand_id="ChEBI:CHEBI:32682"
FT                   /evidence="ECO:0000269|PubMed:25286850,
FT                   ECO:0007744|PDB:4D1O"
FT   BINDING         446
FT                   /ligand="(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin"
FT                   /ligand_id="ChEBI:CHEBI:59560"
FT                   /evidence="ECO:0000269|PubMed:25286850,
FT                   ECO:0007744|PDB:4D1O"
FT   BINDING         447
FT                   /ligand="(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin"
FT                   /ligand_id="ChEBI:CHEBI:59560"
FT                   /evidence="ECO:0000269|PubMed:25286850,
FT                   ECO:0007744|PDB:4D1O"
FT   BINDING         460
FT                   /ligand="(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin"
FT                   /ligand_id="ChEBI:CHEBI:59560"
FT                   /evidence="ECO:0000269|PubMed:25286850,
FT                   ECO:0007744|PDB:4D1O"
FT   BINDING         475
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /evidence="ECO:0000269|PubMed:25286850,
FT                   ECO:0007744|PDB:4D1O"
FT   BINDING         526
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         527
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         528
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         530
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         572
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         573
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         654
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         661
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         687
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         691
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         776
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         798
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         938
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         940
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         941
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         956
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         958
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         962
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         975
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         976
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         977
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1016
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1049
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1078
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1079
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1085
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1087
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1089
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   MOD_RES         33
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         114
FT                   /note="Phosphoserine; by CDK5"
FT                   /evidence="ECO:0000269|PubMed:20213743"
FT   MOD_RES         495
FT                   /note="Phosphothreonine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:16126727"
FT   MOD_RES         615
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P70313"
FT   MOD_RES         633
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         638
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         836
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1175
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P70313"
FT   MOD_RES         1177
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:16126727,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         1179
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P70313"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000250"
FT   LIPID           15
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   LIPID           26
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         584..625
FT                   /note="ESFAAALMEMSGPYNSSPRPEQHKSYKIRFNSISCSDPLVSS -> EGLTLW
FT                   PRLECSSTITAHCSLNLLDSSNPPTSTSQVVGTTGACHDA (in isoform
FT                   eNOS13C)"
FT                   /evidence="ECO:0000303|PubMed:17264164"
FT                   /id="VSP_042625"
FT   VAR_SEQ         585..614
FT                   /note="SFAAALMEMSGPYNSSPRPEQHKSYKIRFN -> RWGFAMLPRLVSNSWVQA
FT                   IHLPRPPKVLRL (in isoform eNOS13B)"
FT                   /evidence="ECO:0000303|PubMed:17264164"
FT                   /id="VSP_045495"
FT   VAR_SEQ         615..1203
FT                   /note="Missing (in isoform eNOS13B)"
FT                   /evidence="ECO:0000303|PubMed:17264164"
FT                   /id="VSP_045496"
FT   VAR_SEQ         626..1203
FT                   /note="Missing (in isoform eNOS13C)"
FT                   /evidence="ECO:0000303|PubMed:17264164"
FT                   /id="VSP_042626"
FT   VARIANT         112
FT                   /note="R -> Q (in dbSNP:rs3918166)"
FT                   /evidence="ECO:0000269|Ref.12"
FT                   /id="VAR_031218"
FT   VARIANT         298
FT                   /note="D -> E (in dbSNP:rs1799983)"
FT                   /evidence="ECO:0000269|PubMed:11740345,
FT                   ECO:0000269|PubMed:12853948, ECO:0000269|PubMed:1378832,
FT                   ECO:0000269|PubMed:1379542, ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17264164,
FT                   ECO:0000269|PubMed:7519987, ECO:0000269|PubMed:7688726,
FT                   ECO:0000269|PubMed:9737779, ECO:0000269|Ref.11,
FT                   ECO:0000269|Ref.12, ECO:0000269|Ref.13, ECO:0000269|Ref.15,
FT                   ECO:0000269|Ref.8, ECO:0000269|Ref.9"
FT                   /id="VAR_008037"
FT   VARIANT         474
FT                   /note="R -> C (found in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs145805216)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036303"
FT   VARIANT         602
FT                   /note="R -> Q (found in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs145168353)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036304"
FT   VARIANT         665
FT                   /note="R -> H (in dbSNP:rs7792133)"
FT                   /id="VAR_061377"
FT   VARIANT         827
FT                   /note="V -> M (in dbSNP:rs3918232)"
FT                   /evidence="ECO:0000269|Ref.12"
FT                   /id="VAR_031219"
FT   VARIANT         885
FT                   /note="R -> M (in dbSNP:rs3918201)"
FT                   /evidence="ECO:0000269|Ref.12"
FT                   /id="VAR_031220"
FT   VARIANT         982
FT                   /note="Q -> L (in dbSNP:rs3918234)"
FT                   /evidence="ECO:0000269|Ref.12"
FT                   /id="VAR_031221"
FT   MUTAGEN         114
FT                   /note="S->A: Reduced nitrite (NO) production."
FT                   /evidence="ECO:0000269|PubMed:20213743"
FT   CONFLICT        53
FT                   /note="S -> R (in Ref. 17; AAA36373)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        168
FT                   /note="S -> G (in Ref. 10; BAG37648)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        414
FT                   /note="K -> R (in Ref. 10; BAF85617)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        489
FT                   /note="G -> S (in Ref. 18; AAD14336)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        567
FT                   /note="V -> W (in Ref. 5; CAA53950)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1150
FT                   /note="R -> RQ (in Ref. 6; BAA05652)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1194
FT                   /note="D -> E (in Ref. 5; CAA53950)"
FT                   /evidence="ECO:0000305"
FT   STRAND          70..73
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   TURN            74..76
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   STRAND          79..81
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           84..87
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   STRAND          88..90
FT                   /evidence="ECO:0007829|PDB:3NOS"
FT   STRAND          104..107
FT                   /evidence="ECO:0007829|PDB:6NH3"
FT   HELIX           120..137
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   STRAND          141..143
FT                   /evidence="ECO:0007829|PDB:6NH7"
FT   HELIX           144..160
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           167..179
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           187..189
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   STRAND          194..197
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           204..219
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           220..222
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   STRAND          227..230
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   STRAND          236..238
FT                   /evidence="ECO:0007829|PDB:6NH7"
FT   STRAND          245..249
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   STRAND          253..255
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   STRAND          257..259
FT                   /evidence="ECO:0007829|PDB:6AV6"
FT   STRAND          261..263
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           265..267
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           268..276
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   STRAND          284..286
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   STRAND          291..294
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   STRAND          296..298
FT                   /evidence="ECO:0007829|PDB:8UFT"
FT   STRAND          301..303
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           307..309
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   STRAND          312..314
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           323..326
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   STRAND          329..332
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   STRAND          340..343
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   STRAND          346..349
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           359..363
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           365..368
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   TURN            370..373
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           376..382
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           390..392
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           394..412
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           420..438
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           445..448
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   STRAND          451..453
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           454..456
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           458..461
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   STRAND          465..467
FT                   /evidence="ECO:0007829|PDB:7UAO"
FT   STRAND          470..474
FT                   /evidence="ECO:0007829|PDB:4D1P"
FT   HELIX           496..506
FT                   /evidence="ECO:0007829|PDB:1NIW"
FT   HELIX           507..509
FT                   /evidence="ECO:0007829|PDB:1NIW"
SQ   SEQUENCE   1203 AA;  133275 MW;  B761A6D40B1A5649 CRC64;
     MGNLKSVAQE PGPPCGLGLG LGLGLCGKQG PATPAPEPSR APASLLPPAP EHSPPSSPLT
     QPPEGPKFPR VKNWEVGSIT YDTLSAQAQQ DGPCTPRRCL GSLVFPRKLQ GRPSPGPPAP
     EQLLSQARDF INQYYSSIKR SGSQAHEQRL QEVEAEVAAT GTYQLRESEL VFGAKQAWRN
     APRCVGRIQW GKLQVFDARD CRSAQEMFTY ICNHIKYATN RGNLRSAITV FPQRCPGRGD
     FRIWNSQLVR YAGYRQQDGS VRGDPANVEI TELCIQHGWT PGNGRFDVLP LLLQAPDDPP
     ELFLLPPELV LEVPLEHPTL EWFAALGLRW YALPAVSNML LEIGGLEFPA APFSGWYMST
     EIGTRNLCDP HRYNILEDVA VCMDLDTRTT SSLWKDKAAV EINVAVLHSY QLAKVTIVDH
     HAATASFMKH LENEQKARGG CPADWAWIVP PISGSLTPVF HQEMVNYFLS PAFRYQPDPW
     KGSAAKGTGI TRKKTFKEVA NAVKISASLM GTVMAKRVKA TILYGSETGR AQSYAQQLGR
     LFRKAFDPRV LCMDEYDVVS LEHETLVLVV TSTFGNGDPP ENGESFAAAL MEMSGPYNSS
     PRPEQHKSYK IRFNSISCSD PLVSSWRRKR KESSNTDSAG ALGTLRFCVF GLGSRAYPHF
     CAFARAVDTR LEELGGERLL QLGQGDELCG QEEAFRGWAQ AAFQAACETF CVGEDAKAAA
     RDIFSPKRSW KRQRYRLSAQ AEGLQLLPGL IHVHRRKMFQ ATIRSVENLQ SSKSTRATIL
     VRLDTGGQEG LQYQPGDHIG VCPPNRPGLV EALLSRVEDP PAPTEPVAVE QLEKGSPGGP
     PPGWVRDPRL PPCTLRQALT FFLDITSPPS PQLLRLLSTL AEEPREQQEL EALSQDPRRY
     EEWKWFRCPT LLEVLEQFPS VALPAPLLLT QLPLLQPRYY SVSSAPSTHP GEIHLTVAVL
     AYRTQDGLGP LHYGVCSTWL SQLKPGDPVP CFIRGAPSFR LPPDPSLPCI LVGPGTGIAP
     FRGFWQERLH DIESKGLQPT PMTLVFGCRC SQLDHLYRDE VQNAQQRGVF GRVLTAFSRE
     PDNPKTYVQD ILRTELAAEV HRVLCLERGH MFVCGDVTMA TNVLQTVQRI LATEGDMELD
     EAGDVIGVLR DQQRYHEDIF GLTLRTQEVT SRIRTQSFSL QERQLRGAVP WAFDPPGSDT
     NSP
//
